1. Home
  2. OBE vs ARDX Comparison

OBE vs ARDX Comparison

Compare OBE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Obsidian Energy Ltd.

OBE

Obsidian Energy Ltd.

N/A

Current Price

$10.47

Market Cap

713.3M

Sector

Energy

ML Signal

N/A

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

N/A

Current Price

$3.01

Market Cap

797.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OBE
ARDX
Founded
1979
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.3M
797.8M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
OBE
ARDX
Price
$10.47
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $12.80
AVG Volume (30 Days)
581.5K
★ 4.3M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,607,000.00
Revenue This Year
$29.81
$19.21
Revenue Next Year
$13.68
$28.19
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$5.47
$2.96
52 Week High
$14.59
$8.40

Technical Indicators

Market Signals
Indicator
OBE
ARDX
Relative Strength Index (RSI) 38.22 37.18
Support Level $10.44 N/A
Resistance Level $10.92 $3.35
Average True Range (ATR) 0.56 0.13
MACD -0.07 0.01
Stochastic Oscillator 7.73 15.19

Price Performance

Historical Comparison
OBE
ARDX

About OBE Obsidian Energy Ltd.

Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Sale of Oil.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: